Expand / Collapse search
Watch TV
Menu

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

Published | Updated

Merck &, Questcor Pharmaceuticals, Other Stocks Hit 52-Week Highs Monday

Here are nine stocks that set 52-week highs:

  • While trading on below-average volume, Merck & (NYSE:MRK) improved today, reaching and then surpassing its previous 52-week high of $41.96. It peaked at $42.10. The stock price is up 1.3% with a volume of 7.8 million shares. Shares are up over the last two months, having risen $3.97 (10.4%) from a price of $38.09 on May 9, 2012. The stock is trading 7.1% above its 50-day moving average and 9.2% above its 200-day moving average.
  • The share price of Questcor Pharmaceuticals (NASDAQ:QCOR) went up today, reaching and then surpassing its previous 52-week high of $54.30. The stock was trading on above-average volume. On volume of four million shares, the stock has risen 11.5%. The stock is trading 18.7% above its 50-day moving average and 25.5% above its 200-day moving average.
  • The share price of American Capital Agency (NASDAQ:AGNC) increased today, reaching and then surpassing its previous 52-week high of $34.32. In spite of its performance and peak price of $34.73, the stock was trading on below-average volume. While trading at a volume of 2.6 million, the stock price has risen 1.2%. Share price is up, having risen $2.07 (6.3%) from $32.61 on June 7, 2012. The stock is trading 5.7% above its 50-day moving average and 11.3% above its 200-day moving average.
  • While trading on below-average volume, BioMarin Pharmaceutical (NASDAQ:BMRN) rose today, reaching and then surpassing its previous 52-week high of $42.37. It peaked at $42.42. The stock price has risen 3.9% on a volume of 1.1 million shares. The stock has risen $10.10 (31.3%) over the last three months from a price of $32.28 on April 11, 2012. The stock is trading 12% above its 50-day moving average and 15.5% above its 200-day moving average.
  • The share price of Incyte Corporation (NASDAQ:INCY) went up today, reaching and then surpassing its previous 52-week high of $25.54. In spite of its performance and peak price of $26.14, the stock was trading on below-average volume. Shares have gained 2.2% on volume of 742,274 shares. The stock is trading 13% above its 50-day moving average and 24.7% above its 200-day moving average.
  • While trading on below-average volume, Spectrum Pharmaceuticals (NASDAQ:SPPI) increased today, reaching and then surpassing its previous 52-week high of $16.98. It peaked at $17.25. The stock is up 1.6% with 736,612 shares changing hands. The stock is trading 30.7% above its 50-day moving average and 26.2% above its 200-day moving average.
  • The share price of ISIS Pharmaceuticals (NASDAQ:ISIS) improved today, reaching and then surpassing its previous 52-week high of $13.27. In spite of its performance and peak price of $13.58, the stock was trading on below-average volume. Shares have risen 2.9%, trading at a volume of 571,604 shares. The stock is trading 25% above its 50-day moving average and 34% above its 200-day moving average.
  • While trading on below-average volume, Theravance (NASDAQ:THRX) rose today, reaching and then surpassing its previous 52-week high of $28. It peaked at $28.16. The stock price has gained 1.8% with 165,292 shares moving. The stock is trading 33% above its 50-day moving average and 27.4% above its 200-day moving average.
  • The share price of Delek US Holdings (NYSE:DK) increased today, reaching and then surpassing its previous 52-week high of $19. In spite of its performance and peak price of $19.32, the stock was trading on below-average volume. The stock price is up 2.6% with a volume of 194,121 shares. Share price is up $3.14 (19.6%) from $16.04 on June 7, 2012. The stock is trading 14% above its 50-day moving average and 22.3% above its 200-day moving average.